Insider · CIK 0002046214
Cristin Rothfuss
officer
Files at SRPT (Sarepta Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | SRPT Sarepta Therapeutics, Inc. | FTax withholding Common Stock | -22,025 | $22.22 | $489k | 115,519 | 34 d ago |
| Nov 26, 2024 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Common Stock | +2,000 | $0.00 | $0 | 13,817 | Nov 29, 2024 |
| Nov 26, 2024 | SRPT Sarepta Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +4,000 | $0.00 | $0 | 4,000 | Nov 29, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.